Rivastigmine Patent Expiration
Rivastigmine is Used for managing symptoms of Alzheimer's dementia. It was first introduced by Sandoz Inc
Rivastigmine Patents
Given below is the list of patents protecting Rivastigmine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Exelon | US6316023 | TTS containing an antioxidant |
Jan 08, 2019
(Expired) | Sandoz |
| Exelon | US6335031 | TTS containing an antioxidant |
Jan 08, 2019
(Expired) | Sandoz |
| Exelon | US5602176 | Phenyl carbamate |
Feb 11, 2014
(Expired) | Sandoz |
| Exelon | US4948807 | Phenyl carbamates |
Aug 14, 2012
(Expired) | Sandoz |
Rivastigmine's Family Patents
Explore Our Curated Drug Screens
Rivastigmine Generic API Manufacturers
Several generic applications have been filed for Rivastigmine. The first generic version for Rivastigmine was by Alvogen Inc and was approved on Aug 31, 2015. And the latest generic version is by Breckenridge Pharmaceutical Inc and was approved on Nov 26, 2019.
Given below is the list of companies who have filed for Rivastigmine generic, along with the locations of their manufacturing plants worldwide.
1. ALVOGEN
Alvogen Inc has filed for 3 different strengths of generic version for Rivastigmine. Given below are the details of the strengths of this generic introduced by Alvogen.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 13.3MG/24HR | film, extended release | Prescription | TRANSDERMAL | AB | Aug 31, 2015 |
| 4.6MG/24HR | film, extended release | Prescription | TRANSDERMAL | AB | Sep 3, 2015 |
| 9.5MG/24HR | film, extended release | Prescription | TRANSDERMAL | AB | Sep 3, 2015 |
Manufacturing Plant Locations New
Alvogen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Alvogen as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
2. AMNEAL PHARMS
Amneal Pharmaceuticals Of New York Llc has filed for 3 different strengths of generic version for Rivastigmine. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 4.6MG/24HR | film, extended release | Prescription | TRANSDERMAL | AB | Jan 8, 2019 |
| 13.3MG/24HR | film, extended release | Prescription | TRANSDERMAL | AB | Jan 8, 2019 |
| 9.5MG/24HR | film, extended release | Prescription | TRANSDERMAL | AB | Jan 8, 2019 |
3. BRECKENRIDGE
Breckenridge Pharmaceutical Inc has filed for 3 different strengths of generic version for Rivastigmine. Given below are the details of the strengths of this generic introduced by Breckenridge.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 4.6MG/24HR | film, extended release | Prescription | TRANSDERMAL | AB | Nov 26, 2019 |
| 9.5MG/24HR | film, extended release | Prescription | TRANSDERMAL | AB | Nov 26, 2019 |
| 13.3MG/24HR | film, extended release | Prescription | TRANSDERMAL | AB | Nov 26, 2019 |
Manufacturing Plant Locations New
Breckenridge's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Breckenridge as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
4. MYLAN TECHNOLOGIES
Mylan Technologies Inc has filed for 3 different strengths of generic version for Rivastigmine. Given below are the details of the strengths of this generic introduced by Mylan Technologies.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 4.6MG/24HR | film, extended release | Prescription | TRANSDERMAL | AB | Jun 20, 2018 |
| 9.5MG/24HR | film, extended release | Prescription | TRANSDERMAL | AB | Jun 20, 2018 |
| 13.3MG/24HR | film, extended release | Prescription | TRANSDERMAL | AB | Jun 20, 2018 |
Manufacturing Plant Locations New
Mylan Technologies's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Mylan Technologies as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
5. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Rivastigmine. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 4.6MG/24HR | film, extended release | Prescription | TRANSDERMAL | AB | Mar 4, 2019 |
| 9.5MG/24HR | film, extended release | Prescription | TRANSDERMAL | AB | Mar 4, 2019 |
| 13.3MG/24HR | film, extended release | Prescription | TRANSDERMAL | AB | Mar 4, 2019 |